PNTG
Pennant GroupBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-21
Current thesis
Pennant enters 2026 with strong recent operating momentum, explicit EBITDA and EPS guidance, and a broader footprint after 2025 expansion. If integration stays clean and former UnitedHealth/Amedisys assets ramp as planned, earnings power can keep compounding from here.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -1.9.
What can break
Acquisition pacing that outruns local operating bandwidth or balance-sheet flexibility
Momentum
84
Value
54
Sentiment
41
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $33.00 · Bull $38.00 · Bear $25.50
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $45.00
Why
Momentum84 · Δ7d -1.9
Value54 · Δ7d -0.3
Sentiment41 · Δ7d -4.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
84
26% active weight
Current posture
7d trendSoftening
Δ7d
-1.9
Δ21d
+31.0
Value
54
39% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-0.3
Sentiment
41
34% active weight
Current posture
7d trendSoftening
Δ7d
-4.3
Δ21d
-13.5
Why this grade
Composite grade B. Momentum 83.5 / Value 53.6 / Sentiment 41.3
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$1.44B
Beta
1.27
Shares Out
34.77M
P/E (TTM)
37.6
P/S (TTM)
1.16
P/FCF (TTM)
35.28
Rev YoY
+36.0%
EPS YoY
+7.8%
Gross Margin
+12.9%
Op Margin
+5.2%
Net Debt
$442.8M
Current Ratio
1.19
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology